GAIL GRUNKEMEYER: Open Payments
NPI 1336602671 · GROSSE POINTE WOODS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,922 in 34 payments from 12 companies in 2025. Trend: 2023 $476 · 2024 $1,239 · 2025 $1,922
Long term medical supply or device loan: $1,147Food & beverage: $734Education: $40
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $1,249 |
| GlaxoSmithKline, LLC. | 1 | $158 |
| Astellas Pharma US Inc | 2 | $144 |
| Tactile Systems Technology Inc | 3 | $120 |
| Gilead Sciences, Inc. | 3 | $70 |
| Aveo Pharmaceuticals, Inc. | 2 | $37 |
| Stemline Therapeutics Inc. | 1 | $31 |
| Geron Corporation | 1 | $30 |
| Syndax Pharmaceuticals, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $24 |
Products named: KISQALI, SHINGRIX, Padcev, Flexitouch Plus, Trodelvy, FOTIVDA, Orserdu, RYTELO.
Industry payments across MI — which companies pay providers there.
